Free Republic 2nd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $79,800
98%  
Woo hoo!! And we're now over 98%!! Thank you all very much!! God bless.

Keyword: libtayo

Brevity: Headers | « Text »
  • In first for EU, anti-skin cancer drug approved

    04/27/2019 12:04:45 PM PDT · by Olog-hai · 13 replies
    French pharmaceutical giant Sanofi on Friday said the European Medicines Agency had conditionally approved its anti-cancer drug Libtayo, the first drug of its kind to be authorized for use in the EU. The tumor-reducing drug is aimed at patients with the second most common form of skin cancer — cutaneous squamous cell carcinoma (CSCC) — whose cancer is advanced, and who are not candidates for surgery or radiation therapy. […] The US Food and Drug Administration (FDA) approved Libtayo in September 2018, while Health Canada gave it the conditional green light earlier this month. …